Salud Pública de México (Oct 2019)

Challenges to regulate products containing bisphenol A: Implications for policy

  • Nicolas D. Mandel,
  • Brenda Gamboa-Loira,
  • Mariano E. Cebrián,
  • Ángel Mérida-Ortega,
  • Lizbeth López-Carrillo

DOI
https://doi.org/10.21149/10411
Journal volume & issue
Vol. 61, no. 5, sep-oct
pp. 692 – 697

Abstract

Read online

Bisphenol A (BPA), found in plastics and epoxy resins, is one of the most studied chemicals. BPA is regarded as an endocrine disruptor and has been related to adverse health effects in humans. However, some regulatory agencies around the world have concluded that BPA is safe at current human exposure levels. As the scientific community attempts to settle the debate on BPA’s health effects, regulatory agen­cies have been put into a challenging public health policy situation. The United States has implemented no regulatory actions due to safety concerns, while Europe has used the precautionary principle to guide its regulation in the face of scientific uncertainty. In this paper, we explore the debate surrounding BPA regulation and the possibility for countries to introduce guidelines, using Mexico as an example. Policy change determinants analysis suggest that countries can and should impose regulations on BPA.

Keywords